Table 2.
Factor | Number (%) | OR (95% CI) | |
---|---|---|---|
Patients | 106 (6.7) | ||
Diabetic nephropathy | No | 90 (7.7) | |
Yes | 16 (4.1) | 0.53 (0.31–0.91)a | |
Comorbidity | |||
DM | No | 78 (7.7) | |
Yes | 28 (5.2) | 0.66 (0.42–1.03)0.06 | |
Cancer | No | 80 (6.1) | |
Yes | 26 (10.1) | 1.70 (1.07–2.70)a | |
Comorbidity number | 0 | 54 (8.0) | 1.00 (Referent) |
Subgroups | 1 | 23 (4.9) | 0.59 (0.36–0.98)a |
>1 | 29 (6.6) | 0.82 (0.51–1.31) | |
Pre-dialysis course | |||
Late referral (<3 months) | No | 42 (3.6) | |
Yes | 55 (18.4) | 5.75 (3.77–8.79)c,C | |
Suboptimal DI | No | 15 (1.6) | |
Yes | 91 (14.2) | 9.63 (5.52–16.8)c,C | |
eGFR decrease 3–0 months prior to dialysis (mL/min/1.73 m2/month) |
<1 >1 |
10 (1.5) 47 (9.1) |
6.70 (3.35–13.8)c |
Biochemistry | |||
eGFR (mL/min/1.73 m2) | ≥7 | 32 (4.5) | |
<7 | 73 (8.8) | 2.04 (1.33–3.14)c | |
Albumin (g/L) | <30 | 45 (9.4) | 2.37 (1.39–4.05)b |
30–34.9 | 24 (6.0) | 1.47 (0.80–2.68) | |
≥35 | 21 (4.1)b | 1.00 (Referent) | |
CRP (mg/L) | <50 | 67 (6.0) | |
≥50 | 36 (11.8) | 2.04 (1.33–3.13)c | |
Initial dialysis | |||
Dialysis cause | Clinical | 44 (4.7) | |
Biochemical | 59 (10.2)c | 2.31 (1.54–3.47)c | |
Life-threatening cause | Not primary | 75 (6.1) | |
Primary | 29 (9.9)a | 1.66 (1.06–2.58)a | |
Hospital | |||
University hospital | No | 5 (1.9) | |
Yes | 101 (7.8)c | 4.32 (1.74–10.7)b,B | |
Home dialysis first policy | No | 45 (13.4) | |
Yes | 61 (4.9) | 0.33 (0.22.0.50)c,C | |
Physician age | <50 | 43 (9.0) | |
≥50 | 22 (4.8) | 0.51 (0.30–0.87)a | |
Nephrologist vintage | <10 | 18 (4.5) | |
≥10 | 47 (8.8) | 2.03 (1.16–3.55)a |
Univariate analysis: aP < 0.05, bP < 0.01, cP < 0.001. Multivariable analysis: AP < 0.05, BP < 0.01, CP < 0.001. Only variables significant in the univariate analysis were included in the multivariable analysis. Comparison to all other patients. Significant factors only. Bold type: independent significant factors on multivariable analysis.